Scancell Holdings PLC. revenue for the last year amounted to 6.62 M USD, the most of which — 6.62 M USD — came from its highest performing source at the moment, Novel Vaccine and Antibody Medicines, the year earlier bringing 0.00 USD. The greatest contribution to the revenue figure was made by United Kingdom — last year it brought Scancell Holdings PLC. 6.62 M USD, and the year before that — 0.00 USD.